Angela Nan

Angela Nan is a scientist with extensive experience in research and development within the biotechnology and pharmaceutical sectors. Currently serving as Scientist I at Tome Biosciences, Angela focuses on translational derisking and the development of novel gene editing technologies. Previously held roles include Principal Research Associate and Senior Research Associate, where responsibilities included method development for therapeutic efficacy and tech transfer for a growing startup. Angela has also worked as a Senior Research Associate at Triplet Therapeutics, developing assays for antibody-conjugated therapies, and has experience in pre-clinical DMPK research at Kintai Therapeutics and analytical chemistry at Frontida BioPharm. Angela holds a Bachelor's Degree in Geochemistry from Caltech, where research involvement spanned mineralogy and coral studies.